Search
Atabecestat
go.drugbank.com/drugs/DB15307InvestigationalAtabecestat is under investigation in clinical trial NCT02211079 (A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9,
ABP-700
go.drugbank.com/drugs/DB15411InvestigationalABP-700 is under investigation in clinical trial NCT02800590 (Study to Investigate the Safety and Efficacy of 3 Dosing Regimens of ABP-700 for Procedural Sedation in Adult Participants Undergoing Colonoscopy
Categories: GABA-A Receptor AgonistsCarumonam
go.drugbank.com/drugs/DB13553ExperimentalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseBrodimoprim
go.drugbank.com/drugs/DB13795ExperimentalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseMUC1 Dendritic Cell Vaccine
go.drugbank.com/drugs/DB05477InvestigationalThese cells are then given back to a patient as a vaccine in order to allow for a potent immune response to cancer. … Dendritic Cell Therapy involves the harvesting of blood cells (ie monocytes or macrophages) from a patient and processing them in the laboratory to produce a greater than typical Dendritic Cell concentration
LSZ-102
go.drugbank.com/drugs/DB15362InvestigationalLSZ-102 is under investigation in clinical trial NCT02734615 (Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers).
Piromidic acid
go.drugbank.com/drugs/DB13744InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseTribenoside
go.drugbank.com/drugs/DB13227InvestigationalAnti-inflammatory agent used in edema of extremities, varicose veins & phlebitis.
Categories: Agents for Treatment of Hemorrhoids and Anal Fissures for Topical UseGlypromate
go.drugbank.com/drugs/DB05633ExperimentalNeuren Pharmaceuticals was developing Glypromate (glycine-proline glutamate), a naturally occurring small-molecule neuroprotectant derived from IGF-1 which inhibits caspase III dependent apoptosis, for
Synonyms: Gly-pro-gluLaquinimod
go.drugbank.com/drugs/DB06685InvestigationalIt is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod.